Mutated EGFR-IN-1
- CAS No.
- 1421372-66-8
- Chemical Name:
- Mutated EGFR-IN-1
- Synonyms
- AZD9291 intermediate;OMT-3;CS-1173;HY-78869;AZD9291 3;AZD9291DA;AZD9291 N-2;AZD9291 int-5;Osimertinib N-2;AZD9291 INT1 N-2
- CBNumber:
- CB22715656
- Molecular Formula:
- C25H31N7O
- Molecular Weight:
- 445.56
- MOL File:
- 1421372-66-8.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/9/25 11:21:29
Boiling point | 676.5±65.0 °C(Predicted) |
---|---|
Density | 1.21±0.1 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | DMSO: ≥ 75 mg/mL (168.33 mM) |
pka | 9.07±0.28(Predicted) |
form | Powder |
InChIKey | HTNTZPBKKCORTP-UHFFFAOYSA-N |
SMILES | C1(N(CCN(C)C)C)=CC(OC)=C(NC2=NC=CC(C3C4=C(N(C)C=3)C=CC=C4)=N2)C=C1N |
Mutated EGFR-IN-1 Chemical Properties,Uses,Production
Uses
N1-?[2-?(Dimethylamino)?ethyl]?-?5-?methoxy-?N1-?methyl-?N4-?[4-?(1-?methyl-?1H-?indol-?3-?yl)?-?2-?pyrimidinyl]?-?1,?2,?4-?benzenetriamine can be involved as reactant/reagent in "Schizophrenic" self-assembly of dual thermoresponsive block copolymers bearing a zwitterionic and a non-ionic hydrophilic block.
Mutated EGFR-IN-1 Preparation Products And Raw materials
Global( 212)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Bulat Pharmaceutical Pvt Ltd | +91-8448085659 +91-8448085660 | Haryana, India | 123 | 58 | Inquiry |
ALS INDIA LIFE SCIENCES | +91-8977036379 +91-8977036379 | Hyderabad, India | 1879 | 58 | Inquiry |
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Ashchemie India | 09821323153 | Maharashtra, India | 30 | 58 | Inquiry |
Cangzhou Kangrui Pharma Tech Co. Ltd., | +8618632776803 | China | 733 | 58 | Inquiry |
Henan Fengda Chemical Co., Ltd | +86-371-86557731 +86-13613820652 | China | 20290 | 58 | Inquiry |
Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 | China | 29798 | 60 | Inquiry |
Shanghai Daken Advanced Materials Co.,Ltd | +86-371-66670886 | China | 18656 | 58 | Inquiry |
Mutated EGFR-IN-1
HY-78869
AZD9291DA HCl salt
N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine
AZD9291 int-5
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
1,2,4-Benzenetriamine, N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-
AZD9291 3
N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine
AZD9291 intermediate 4
N1-(2-dimethylaminoethyl)-5-methoxy-N1-methyl-N4-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine
N-(2-dimethylamino-ethyl)-2-methoxy-n-methyl-n-[4-(1-methyl-1h-indol-3-yl)-pyrimidin-2-yl]-5-Amino-benzene-1,4-diamine
AZD9291 Intermediate1
Mereletinib Intermediates
OMT-3
N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)b
N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene
AZD9291DA
N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-
yl)pyrimidin-2-yl)benzene-1,2-triamine
Osimertinib intermediate
Osimertinib analog
Mutated EGFR inhibitor 1
AZD9291 intermediates 3
Osimertinib Intermediate 3
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-m-ethyl-1H-indol-3-yl)-2-pyrimidi-nyl]-1,2,
Mutated EGFR-IN-1 (Osimertinib analog)
AZD9291 N-2
AZD91 intermediate
CS-1173
Osimertinib Impurity 5
AZD9291 INT1 N-2
1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine
AZD9291 intermediate
N1- [2- (dimethylamino) ethyl] -5-methoxy-N1- methyl-N4- [4- (1-methyl-1H-indole-3-yl) -2-pyrimidinyl] -1,2,4-phenyltriamine
Osimertinib N-2
1421372-66-8
AZD9291
Pharmaceutical intermediate
API